Melissa Crespo spoke to Law360 about the Federal Trade Commission (FTC) disclosing its first action under the Health Breach Notification Rule, which hit telehealth and prescription discount company GoodRx with a $1.5 million civil penalty and secured a ban on the platform’s sharing of personal health data for advertising purposes.
“There’s certainly an expectation at this point that sensitive data needs to be treated with heightened protections, and this FTC matter gives more teeth to the idea of specifically having additional protections for sensitive information at the federal level,” Melissa said.
Read the full article.